Key Drivers
- Positive Cash Flow
- Strong Liquidity
- Rising Leverage
AIAI Summary
PODD has shifted from an adoption-driven growth story to a retention-and-quality proof point: investors should hold or add only if management demonstrates stabilizing Type 2 utilization, pod reliability, and margins, as persistent attrition or further corrections could materially reset valuation.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Positive Cash Flow
- •Strong Liquidity
- •Rising Leverage
PODD is profitable and cash-generative with strong liquidity and manageable debt, but weakening working capital, margin pressure, and elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Rebound from lows
- •Below average
- •Resistance overhead
PODD remains cautiously bearish over the last month, with a rebound from $131.96 needing a break above $143.11–$147.48 to strengthen, while weakness below $137.80 risks a retest of lows.
Rebounded sharply from $131.96 to $141.55 within four trading days
Sentiment & News
Key News Insights:
- •Earnings resilience
- •Recall risks
- •Guidance reset
Insulet's earnings and international momentum are offset by slower 2026 growth expectations, recalls, legal scrutiny, and softer analyst sentiment.
Near-term sentiment remains cautious as operational and legal risks may outweigh positive growth catalysts
Similar Companies in Healthcare
Other companies in the same sector with AI ratings